| abstract |
A novel benzodiazepine derivative represented by the general formula (I) or pharmaceutically acceptable salts thereof. These compounds are useful as medicines, in particular, for treating and preventing diseases in which CCK-B receptor and gastrin receptor participate, because they have CCK-B receptor antagonism, gastrin receptor antagonism and the effect of inhibiting gastric juice secretion. (I) |